|
Date: 3/29/2011
Time: 1:00 - 2:15 PM Eastern
Price: $179.00
Registration Deadline: 3/29/2011 10:00:00 AM
Registration For This Event Is Closed
This is the third webinar in the "Advanced Biosafety Webinar Series - Meeting the Challenges of Today's Research".
Adenoviral vectors and novel adjuvants have shown great promise in stimulating an immune response to HIV infection. Research in primates and mice is critical to advancing an understanding of the immune response. This webinar will provide biosafety professionals with the current status of HIV vaccine research, and the methods being used in the field. Further discussion will include the unique challenges present in working with the non-human primate model in HIV vaccine research. This online event will cover: - Utility and limitations of the non-human primate (NHP) model.
- The refinement of the model over the years in terms of understanding what types of NHP studies will be predictive in humans.
- Current NHP studies supporting HIV vaccine development.
- Safe use of HIV vaccines in research involving NHP models.
David Ross Kaufman MD, PhD
Technical Consultant, PureTech Ventures
Physician, Division of Vaccine Research and Infectious Diseases, Beth Israel Deaconess Medical Center David is an Instructor of Medicine in the Division of Vaccine Research and Infectious Diseases at the Beth Israel Deaconess Medical Center in Boston, MA. His research focuses on the evaluation of mucosal immune responses to candidate HIV vaccines, design and evaluation of novel smallpox vaccine candidates, and basic studies of mucosal immune system function. He is the recent recipient of the Early Career Investigator Award from the HIV Vaccine Trials Network, and frequently publishes and presents on the topic of HIV vaccines. David earned a medical degree from Weill Medical College, Cornell University, his doctorate in Molecular Virology from The Rockefeller University, and a Bachelor of Arts from Swarthmore College. For Dr. Kaufman’s current list of publications click here. Ted Myatt, ScD, RBP
Senior Scientist / Biosafety and Biological Hazards Practice Leader, EH&E Ted concentrates his practice on microbiology, exposure assessments of biological agents, biological safety, and investigations of infectious disease outbreaks. As part of his role at EH&E, he acts as a consultant to a number of IBCs, and serves as the biological safety officer and IBC member for Brigham and Women’s Hospital and the Harvard Institutes of Medicine, both located in Boston, Massachusetts. - Biosafety Officers
- Institutional Biosafety Committee (IBC) members
- Environmental Health & Safety (EHS) managers/directors
The registration price ($179) provides you with access to ONE phone connection; an unlimited number of people may listen using the speaker function on your phone or a conferencing unit. Your registration also includes a recording of the event.
Note: The registration confirmation and all program materials will be sent to the email address provided.
To Register and Pay for this webinar by Credit Card : Go to the ONLINE Registration Page.
To Register and Pay by Check: Mail Registration Form and check made payable to Environmental Health & Engineering, Inc., Attn: Julie McCarthy, 117 Fourth Avenue, Needham, MA 02494. Special Discount!
Register for all 3 sessions listed below for $499 (one phone connection per session). - Use of Novel Viral Vectors in Neurobiological Research
January 25, 2011, 1:00 - 2:15 PM Eastern - Coping with Exponential Improvements in Reading and Writing DNA: Understanding the Safety and Regulatory Aspects of Genomic Research
February 22, 2011, 1:00 - 2:15 PM Eastern - Nonhuman Primates as Preclinical Models for HIV Vaccine Development: Challenges and Controversies
March 29, 2011, 1:00 - 2:15 PM Eastern
To register for all 3 webinars and receive the discount, contact Julie McCarthy at 800-825-5343 or at events@eheinc.com.
Return to Workshops & Seminars
|
